STERIS Plc (NYSE:STE) Shares Acquired by Sumitomo Mitsui DS Asset Management Company Ltd
STERIS Plc (NYSE:STE) Shares Acquired by Sumitomo Mitsui DS Asset Management Company Ltd
Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in shares of STERIS plc (NYSE:STE – Get Rating) by 16.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,305 shares of the medical equipment provider's stock after acquiring an additional 1,023 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in STERIS were worth $1,506,000 at the end of the most recent quarter.
根据三井住友DS资产管理有限公司在最近提交给美国证券交易委员会的13F文件中，该公司在第二季度将其在STERIS plc(纽约证券交易所代码：STE-GET评级)的股票持有量增加了16.3%。该公司在此期间额外收购了1,023股后，拥有这家医疗设备提供商的7,305股股票。截至最近一个季度末，三井住友DS资产管理有限公司在STERIS持有的股份价值1,506,000美元。
Several other institutional investors and hedge funds have also bought and sold shares of STE. Tcwp LLC acquired a new stake in STERIS during the 1st quarter valued at approximately $25,000. 1832 Asset Management L.P. purchased a new position in shares of STERIS during the 1st quarter valued at approximately $25,000. Riverview Trust Co purchased a new position in shares of STERIS during the 1st quarter valued at approximately $29,000. J.W. Cole Advisors Inc. purchased a new position in shares of STERIS during the 1st quarter valued at approximately $37,000. Finally, Standard Family Office LLC purchased a new position in shares of STERIS during the 1st quarter valued at approximately $43,000. 92.04% of the stock is currently owned by institutional investors and hedge funds.
其他几家机构投资者和对冲基金也买卖了STE的股票。Tcwp LLC在第一季度收购了STERIS的新股份，价值约2.5万美元。1832资产管理公司在第一季度购买了新的STERIS股票头寸，价值约25,000美元。Riverview Trust Co在第一季度购买了新的STERIS股票头寸，价值约2.9万美元。J.W.Cole Advisors Inc.在第一季度购买了新的STERIS股票头寸，价值约3.7万美元。最后，标准家族办公室有限责任公司在第一季度购买了新的STERIS股票头寸，价值约为43,000美元。92.04%的股票目前由机构投资者和对冲基金持有。
Analyst Ratings Changes
分析师评级发生变化
Several equities analysts have recently weighed in on STE shares. KeyCorp cut their target price on shares of STERIS from $256.00 to $240.00 and set an "overweight" rating for the company in a report on Thursday, August 4th. Piper Sandler started coverage on shares of STERIS in a report on Thursday, July 14th. They set an "overweight" rating and a $240.00 target price for the company. JMP Securities cut their target price on shares of STERIS from $270.00 to $250.00 in a report on Thursday, August 4th. StockNews.com raised shares of STERIS from a "hold" rating to a "buy" rating in a report on Thursday, August 11th. Finally, TheStreet raised shares of STERIS from a "c+" rating to a "b" rating in a report on Tuesday, August 2nd. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $252.00.
几位股票分析师最近纷纷买入STE股票。KeyCorp在8月4日周四的一份报告中将其股票目标价从256.00美元下调至240.00美元，并对该公司设定了“增持”评级。派珀·桑德勒在7月14日星期四的一份报告中开始报道STERIS的股票。他们为该公司设定了“增持”评级和240.00美元的目标价。JMP证券在8月4日星期四的一份报告中将STERIS的股票目标价从270.00美元下调至250.00美元。在8月11日星期四的一份报告中，StockNews.com将STERIS的股票评级从持有上调至买入。最后，华尔街在8月2日星期二的一份报告中将STERIS的股票评级从“c+”上调至“b”。一名研究分析师对该股的评级为持有，六名分析师对该公司股票的评级为买入。根据MarketBeat的数据，该股目前的平均评级为“中等买入”，平均目标价为252.00美元。
STERIS Price Performance
Steris性价比
STERIS Increases Dividend
Steris增加股息
The firm also recently announced a quarterly dividend, which was paid on Friday, September 23rd. Stockholders of record on Wednesday, September 7th were issued a dividend of $0.47 per share. This is a positive change from STERIS's previous quarterly dividend of $0.43. The ex-dividend date was Tuesday, September 6th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 1.12%. STERIS's dividend payout ratio is presently 50.40%.
该公司最近还宣布了季度股息，股息于9月23日(星期五)支付。9月7日星期三，登记在册的股东获得了每股0.47美元的股息。与之前STERIS的季度股息0.43美元相比，这是一个积极的变化。除息日期为9月6日星期二。这意味着年化股息为1.88美元，股息收益率为1.12%。Steris的股息支付率目前为50.40%。
About STERIS
关于斯特里斯
(Get Rating)
(获取评级)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Steris plc在全球范围内提供感染预防和其他程序产品和服务。它通过四个部门运作：医疗保健、应用消毒技术、生命科学和牙科。医疗保健部门提供清洁化学品和无菌保证产品；自动化内窥镜再处理系统和跟踪产品；用于胃肠道(GI)程序的配件、垫圈、消毒器和无菌加工部门运营的其他资本设备；以及直接在手术室使用的设备，包括手术台、灯和连接解决方案，以及设备管理服务。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on STERIS (STE)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 免费获取StockNews.com关于STERIS的研究报告(STE)
- MarketBeat：回顾一周9/19-9/23
- 为什么特斯拉的股票保持弹性？
- 需要关注的2只半导体类股走势逆转
- 小盘股的裁员是楼市的晴雨表吗？
- 好市多盈利后价格疲软是买入的好时机吗？
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Get Rating).
想看看其他对冲基金持有STE吗？访问HoldingsChannel.com获取STERIS plc(纽约证券交易所代码：STE-GET Rating)的最新13F文件和内幕交易。
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.
接受STERIS日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对STERIS和相关公司的最新新闻和分析师评级的每日简要摘要。